<DOC>
	<DOCNO>NCT02574585</DOCNO>
	<brief_summary>The purpose study analyze safety efficacy autologous bone marrow mesenchymal stem cell transplantation patient thoracolumbar chronic complete spinal cord injury .</brief_summary>
	<brief_title>Autologous Mesenchymal Stem Cells Transplantation Thoracolumbar Chronic Complete Spinal Cord Injury Spinal Cord Injury</brief_title>
	<detailed_description>This randomize , non-placebo control , prospective , phase II clinical trial . The study population consist 40 patient spinal cord injury least 12 month , thoracolumbar chronic complete spinal cord injury , ASIA grade A . A practitioner , surgeon nurse review medical record patient determine presence / absence inclusion / exclusion criterion . If patient potential candidate study , interview schedule review confirm his/her eligibility . Patients undergo series clinical neurological assessment also submit follow procedure : - Cell blood count ; - Biochemical analysis ( measurement electrolytes - sodium , potassium , magnesium ) ; - Renal function test ( urea creatinine ) ; - Liver function test ; - Coagulation profile ; - Metabolic profile ( glucose , total cholesterol fraction ) ; - Urine summary culture ; - Serology require blood transfusion marrow transplant Brazil ; - Electrocardiogram ; - Chest X-Ray ; - Bone densitometry ; - Urodynamic study ; - Somatosensory evoked potential ; - Computed tomography thoracic lumbar spine ; - Magnetic resonance image thoracic lumbar spine . Also part preoperative evaluation , patient respond question SF ( Short Form ) -36 questionnaire ( assessment quality life ) questionnaires assessment neuropathic pain . Clinical follow-up kept patient suspend participation study adverse event / laboratory abnormality , patient 's desire , follow insurance protocol . In addition clinical surgical follow-up , specific medical care offer patient experience adverse event , stabilization patient , even target date completion study exceed . The candidate include study ask voluntarily participate give inform write consent .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Blunt spinal cord injury thoracolumbar level , T1 L2 , penetrate spinal cord injury , level , provide mechanism injury spinal shock , ischemia hematoma , least 12 month injury ; ASIA grade A ; Signing write consent . Spinal cord injury sharp object , firearm , traumatic congenital cause , even different level spinal cord ; Concomitant brain injury ; Diabetes mellitus type 1 2 define fast glucose 126 mg / use medication medical history ; Infectious process acute / chronic course , confirm additional test / medical history ; Immunodeficiency , autoimmune disease neoplastic process , confirm additional test / medical history ; Terminal , neurodegenerative , primary hematologic musculoskeletal disease confirm additional test / past medical history ; Osteopathies reflect increase risk bone marrow puncture ; Coagulopathies ; Severe organ failure ( heart , kidney liver ) , confirm additional test medical history ; Pregnancy lactation ; Clinical complication hinder contraindicate surgical procedure ; Use metallic implant near vascular structure ( cardiac pacemaker ) , contraindication magnetic resonance imaging ; Psychiatric disorder , psychosocial cognitive impairment confirm medical evaluation ; Abusive use alcohol / illegal substance use ; Participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Spinal cord injury</keyword>
	<keyword>Paraplegia</keyword>
	<keyword>Stem cell</keyword>
	<keyword>Mesenchymal cell</keyword>
</DOC>